Regulation of aldo-keto reductase AKR1B10 gene expression: Involvement of transcription factor Nrf2

Chemico-Biological Interactions

Volumn 191, Issue 1-3, 2011, Pages 185-191

  Nishinaka, Toru ^a   Miura, Takeshi ^a   Okumura, Manami ^a   Nakao, Fumika ^a   Nakamura, Haruka ^a   Terada, Tomoyuki ^a  

^a OSAKA OHTANI UNIVERSITY   (Japan)

Author keywords

AKR1B10; Aldo keto reductase; Ethoxyquin; Microsatellite; Nrf2; Promoter

Indexed keywords

ALDEHYDE REDUCTASE; ALDO KETO REDUCTASE FAMILY 1 MEMBER B10; ETHOXYQUIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; CANCER CELL; CONFERENCE PAPER; CONTROLLED STUDY; DNA BINDING; DNA FLANKING REGION; DNA POLYMORPHISM; ENZYME REGULATION; ENZYME SPECIFICITY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ALDEHYDE REDUCTASE; BASE SEQUENCE; CELL LINE, TUMOR; ETHOXYQUIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICROSATELLITE REPEATS; NF-E2-RELATED FACTOR 2; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 79957558400     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2011.01.026     Document Type: Conference Paper

References (36)

1. J.M. Jez, T.G. Flynn, T.M. Penning, A new nomenclature for the aldo-keto reductase superfamily, Biochem. Pharmacol. 54 (1997) 639-647.
2. C. Yabe-Nishimura, Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications, Pharmacol. Rev. 50 (1998) 21-33.
3. D. Cao, S.T. Fan, S.S. Chung, Identification and characterization of a novel human aldose reductase-like gene, J. Biol. Chem. 273 (1998) 11429-11435.
4. H.J. Martin, U. Breyer-Pfaff, V. Wsol, S. Venz, S. Block, E. Maser, Purification and characterization of AKR1B10 from human liver: role in carbonyl reduction of xenobiotics, Drug Metab. Dispos. 34 (2006) 464-470.
5. L. Zhong, Z. Liu, R. Yan, S. Johnson, Y. Zhao, X. Fang, D. Cao, Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels, Biochem. Biophys. Res. Commun. 387 (2009) 245-250.
6. J. Ma, R. Yan, X. Zu, J.M. Cheng, K. Rao, D.F. Liao, D. Cao, Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells, J. Biol. Chem. 283 (2008) 3418-3423.
7. S. Fukumoto, N. Yamauchi, H. Moriguchi, Y. Hippo, A. Watanabe, J. Shibahara, H. Taniguchi, S. Ishikawa, H. Ito, S. Yamamoto, H. Iwanari, M. Hironaka, Y. Ishikawa, T. Niki, Y. Sohara, T. Kodama, M. Nishimura, M. Fukayama, H. Dosaka-Akita, H. Aburatani, Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas, Clin. Cancer Res. 11 (2005) 1776-1785.
8. H. Yoshitake, M. Takahashi, H. Ishikawa, M. Nojima, H. Iwanari, A. Watanabe, H. Aburatani, K. Yoshida, K. Ishi, K. Takamori, H. Ogawa, T. Hamakubo, T. Kodama, Y. Araki, Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer, Int. J. Gynecol. Cancer 17 (2007) 1300-1306. (Pubitemid 350077355)
9. M.D. Bacolod, S.M. Lin, S.P. Johnson, N.S. Bullock, M. Colvin, D.D. Bigner, H.S. Friedman, The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide, Curr. Cancer Drug Targets 8 (2008) 172-179. (Pubitemid 351666854)
10. J. Breton, M.C. Gage, A.W. Hay, J.N. Keen, C.P. Wild, C. Donnellan, J.B. Findlay, L.J. Hardie, Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma, J. Proteome Res. 7 (2008) 1953-1962.
11. T.M. Penning, AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers, Clin. Cancer Res. 11 (2005) 1687-1690.
12. R. Yan, X. Zu, J. Ma, Z. Liu, M. Adeyanju, D. Cao, Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention, Int. J. Cancer 121 (2007) 2301-2306. (Pubitemid 47585613)
13. O. Gallego, F.X. Ruiz, A. Ardevol, M. Dominguez, R. Alvarez, A.R. de Lera, C. Rovira, J. Farres, I. Fita, X. Pares, Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10, Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 20764-20769.
14. F.X. Ruiz, O. Gallego, A. Ardevol, A. Moro, M. Dominguez, S. Alvarez, R. Alvarez, A.R. de Lera, C. Rovira, I. Fita, X. Pares, J. Farres, Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels, Chem. Biol. Interact. 178 (2009) 171-177.
15. A.M. Quinn, R.G. Harvey, T.M. Penning, Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10, Chem. Res. Toxicol. 21 (2008) 2207-2215.
16. G.K. Balendiran, H.J. Martin, Y. El-Hawari, E. Maser, Cancer biomarker AKR1B10 and carbonyl metabolism, Chem. Biol. Interact. 178 (2009) 134-137.
17. H.J. Martin, E. Maser, Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes, Chem. Biol. Interact. 178 (2009) 145-150.
18. E.K. Lee, W.T. Regenold, P. Shapiro, Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases, Anticancer Drugs 13 (2002) 859-868.
19. K.W. Lee, B.C. Ko, Z. Jiang, D. Cao, S.S. Chung, Overexpression of aldose reductase in liver cancers may contribute to drug resistance, Anticancer Drugs 12 (2001) 129-132. (Pubitemid 32207361)
20. Z. Liu, L. Zhong, P.A. Krishack, S. Robbins, J.X. Cao, Y. Zhao, S. Chung, D. Cao, Structure and promoter characterization of aldo-keto reductase family 1 B10 gene, Gene 437 (2009) 39-44.
21. T. Nguyen, H.C. Huang, C.B. Pickett, Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK, J. Biol. Chem. 275 (2000) 15466-15473. (Pubitemid 30337278)
22. T. Nishinaka, C. Yabe-Nishimura, Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene, J. Pharmacol. Sci. 97 (2005) 43-51.
23. J.D. Hayes, S.A. Chanas, C.J. Henderson, M. McMahon, C. Sun, G.J. Moffat, C.R. Wolf, M. Yamamoto, The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin, Biochem. Soc. Trans. 28 (2000) 33-41.
24. M. McMahon, K. Itoh, M. Yamamoto, S.A. Chanas, C.J. Henderson, L.I. McLellan, C.R. Wolf, C. Cavin, J.D. Hayes, The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes, Cancer Res. 61 (2001) 3299-3307. (Pubitemid 32695017)
25. T. Nishinaka, Y. Ichijo, M. Ito, M. Kimura, M. Katsuyama, K. Iwata, T. Miura, T. Terada, C. Yabe-Nishimura, Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element, Toxicol. Lett. 170 (2007) 238-247.
26. K. Itoh, K. Igarashi, N. Hayashi, M. Nishizawa, M. Yamamoto, Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins, Mol. Cell. Biol. 15 (1995) 4184-4193.
27. T.H. Rushmore, M.R. Morton, C.B. Pickett, The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity, J. Biol. Chem. 266 (1991) 11632-11639. (Pubitemid 21906996)
28. H. Ikeda, S. Nishi, M. Sakai, Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis, Biochem. J. 380 (2004) 515-521. (Pubitemid 38788124)
29. Z.Q. Jiang, C. Chen, B. Yang, V. Hebbar, A.N. Kong, Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers, Life Sci. 72 (2003) 2243-2253. (Pubitemid 36287361)
30. A. Kobayashi, M.I. Kang, H. Okawa, M. Ohtsuji, Y. Zenke, T. Chiba, K. Igarashi, M. Yamamoto, Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2, Mol. Cell. Biol. 24 (2004) 7130-7139. (Pubitemid 39014439)
31. K.I. Tong, B. Padmanabhan, A. Kobayashi, C. Shang, Y. Hirotsu, S. Yokoyama, M. Yamamoto, Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response, Mol. Cell. Biol. 27 (2007) 7511-7521. (Pubitemid 350033657)
32. A.K. MacLeod, M. McMahon, S.M. Plummer, L.G. Higgins, T.M. Penning, K. Igarashi, J.D. Hayes, Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds, Carcinogenesis 30 (2009) 1571-1580.
33. T Nishinaka, C. Yabe-Nishimura, EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress, Free Radic. Biol. Med. 31 (2001) 205-216. (Pubitemid 32607587)
34. L.V. Favreau, C.B. Pickett, The rat quinone reductase antioxidant response element. Identification of the nucleotide sequence required for basal and inducible activity and detection of antioxidant response element-binding proteins in hepatoma and non-hepatoma cell lines, J. Biol. Chem. 270 (1995) 24468-24474.
35. J.M. Lee, M.J. Calkins, K. Chan, Y.W. Kan, J.A. Johnson, Identification of the NFE2- related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis, J. Biol. Chem. 278 (2003) 12029-12038.
36. R.K. Thimmulappa, K.H. Mai, S. Srisuma, T.W. Kensler, M. Yamamoto, S. Biswal, Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray, Cancer Res. 62 (2002) 5196-5203. (Pubitemid 35033454)